Breif Introduction:
Halide ligands have an extensive history, with the first complexes being recognized in the early 1800's. More recently, during the 1960's a metal complex known as cis-platin was found to have anticancer properties. Cis-platin consists of a platnium center surrounded by two chloride ligand and two amine ligands in the cis conformation. Today, cis-platin and other derivatives, have become a cornerstone of many chemotherapy treatments, particularly in the treatment of testicular, ovarian, bladder, and lung cancer.
Electron Contribution: 2 electrons (anionic ligand).
Key Features:
Halide ligands primarily act as σ-donors, bonding through their lone pairs. Their bonding strength and character vary across the halogen group:
Halides are generally considered hard bases, but get softer decending the group due to increasing polarizability.
Halide ligands are often introducted or removed during synthesis and functionalization of organometallic complexes.
MLnX + AgBF4 --> [MLn]+ + AgX↓
MCln + nNaI --> MIn + nNaCl
Electron Donor Ability:
Leaving Group Ability: Halides act as leaving groups in many substitution and reductive elimination reactions.
Sterric Effects: Larger halides (e.g. I-) introduce sterric hinderance which can affect the geometry and reactivity of the complex.
Include image:
Synthesis: Typically synthesized from K2[PtCl4].
Chemical Reactivity: Relatively stable in solid state, but readily undergoes aquation in aqueous or physiological conditions.
DNA Binding: Once inside the cell, low chloride concentrration promotes aquation. The resulting aqua complex binds to DNA through-
Effect on DNA:
Halide ligands are used in a wide variety of reactions with different purposes, and are even found in cutting edge cancer technology.
[NiCl4]2- with tetrahedral geometry and labeled halides.